Hepatic stimulator substance activity in animal model of fulminant hepatic failure and encephalopathy

Digestive Diseases and Sciences

Volumn 47, Issue 10, 2002, Pages 2170-2178

  Margeli, Alexandra P ^a,b   Manolis, Evangelos ^c   Skaltsas, Spyridon N ^a   Tsarpalis, Kyriakos S ^a   Mykoniatis, Michael G ^a   Theocharis, Stamatios E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Children's Hospital   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Fulminant hepatic failure; Hepatic encephalopathy; Hepatic stimulator substance; Thioacetamide

Indexed keywords

GROWTH FACTOR; HEPATIC STIMULATOR SUBSTANCE; THIOACETAMIDE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; HEPATIC ENCEPHALOPATHY; LIVER BIOPSY; LIVER CELL; LIVER FAILURE; LIVER INJURY; LIVER REGENERATION; MALE; MITOSIS INDEX; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; GROWTH SUBSTANCES; HEPATIC ENCEPHALOPATHY; HUMANS; INJECTIONS, INTRAPERITONEAL; LIVER; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER REGENERATION; MALE; NECROSIS; PEPTIDES; RATS; RATS, WISTAR; THIOACETAMIDE; UP-REGULATION;

EID: 0036798930     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020166706833     Document Type: Article

References (63)

1. O' Grady J, Schalman SW, Williams R: Acute liver failure: redefining the syndrome. Lancet 324:273-275, 1993
2. Lee WR: Acute liver failure. N Engl J Med 329:1867-1872, 1993
3. Ferenci P: Treatment of hepatic encephalopathy. Indian J Gastroenterol 20(suppl 1):C90-C94, 2001
4. Blei AT: Diagnosis and treatment of hepatic encephalopathy. Baillieres Best Pract Res Clin Gastroenterol 14:959-974, 2000
5. Riordan SM, Williams R: Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 32(suppl 1):63-76, 2000
6. VanThiel DH, Brems J, Nadir A, Idilman R, Colantoni A, Holt D, Edelstein S: Liver transplantation for fulminant hepatic failure. J Gastroenterol 36:1-4, 2001
7. Zimmermann C, Ferenci P, Pifl C, Yurdaydin C, Ebner J, Lassmann H, Roth E, Hortnagl H: Hepatic encephalopathy in thioacetamide induced acute liver failure in rats: characterization of an improved model and study of amino acidergic neurotransmission. Hepatology 9:595-601, 1989
8. Larsen FS, Knudsen GM, Paulson OB, Vilstrup H: Cerebral blood flow autoregulation is absent in rats with thioacetamide-induced hepatic failure. J Hepatol 21:491-495, 1994
9. Bruck R, Aeed H, Shirin H, Matas Z, Zaidel L, Avri Y, Halpern Z: The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protects rats against thioacetamide-induced fulminant hepatic failure. J Hepatol 31:27-38, 1999
10. Chieli E, Malvaldi G: Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide. Toxicology 31:41-52, 1984
11. Porter WR, Neal RA: Metabolism of thioacetamide and thioacetamide S-oxide by rat microsomes. Drug Metab Dispos 6:379-388, 1978
12. Hunter AL, Holscher MA, Neal RA: Thioacetamide-induced hepatic necrosis. Involvement of the mixed-function oxidase enzyme system. J Pharmacol Exper Ther 200:439-448, 1977
13. Slater TF: Free radical mechanisms in tissue injury. Biochem J 222:1-15, 1984
14. Machlin LJ, Bendich A: Free radical damage: protective role of antioxidant nutrients. FASEB J 1:441-445, 1987
15. Bacon BR, Tavill AT, Brittenham GM, Park CH, Recknagel RO: Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 71:429-439, 1983
16. Kyle ME, Miccadei S, Nakae D, Farber JL: Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen. Biochem Biophys Res Commun 149:889-896, 1987
17. Shaw S, Jayatilleke E, Ross WA, Gordon ER, Leiber CS: Ethanol induced lipid peroxidation: potentiation by long term alcohol feeding and attenuation by methionine. J Lab Clin Med 98:417-424, 1981
18. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL: Plasma tumor necrosis factor-α predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14:255-259, 1990
19. Fleig WE: Liver specific growth factors. Scand J Gastroenterol 23(suppl 151):31-36, 1988
20. LaBrecque DR, Pesh LA: Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol 248:273-284, 1975
21. Fleig WE, Lehmann H. Wagner H, Hoss G, Ditschuneit H: Hepatic regenerative stimulator substance in the rabbit. Relation to liver regeneration after partial hepatectomy. J Hepatol 3:19-26, 1986
22. Francavilla A, Ove P, Polimeno L, Coetzee M, Makowka L, Rose J, Van Thiele DH, Starzl TE: Extraction and partial purification of hepatic stimulatory substance in rats, mice and dogs. Cancer Res 47:5600-5605, 1987
23. Mao-Hua M, Wei A, Bao-Hong Z, Qing S, De-Zheng G: Hepatic stimulator substance protects against acute liver failure induced by carbon tetrachloride poisoning in mice. Hepatology 17:638-644, 1993
24. Zhiqiang Y, Weisong Y, Wenbin Z, Yong C, Yongxing Z: Hepatic stimulator substance from human fetal liver for treatment of experimental hepatic failure. Chin Med J 105(8):676-683, 1992
25. Theocharis SE, Margeli AP, Spiliopoulou C, Skaltsas S, Kittas C, Koutselinis A: Hepatic stimulator substance administration enhances the regenerative capacity of hepatocytes in cadmium-pretreated partially hepatectomized rats. Dig Dis Sci 41(7):1475-1480, 1996
26. Margeli A, Theocharis S, Spiliopoulou C, Horti M, Koutselinis A: Hepatic stimulator substance administration affects cadmium-induced hepatotoxicity in the rat. Int Hepatol Commun 5:128-134, 1996
27. Theocharis SE, Margeli AP, Agapitos EV, Mykoniatis MG, Kittas CN, Davaris PS: Effect of hepatic stimulator substance administration on tissue regeneration due to thioacetamide induced liver injury in rats. Scand J Gastroenterol 33:656-663, 1998
28. Margeli AP, Skaltsas S. Spiliopoulou C, Mykoniatis MG, Theocharis SE: Hepatic stimulator substance activity in the liver of thioacetamide-intoxicated rats. Liver 19:519-525, 1999
29. Geller D: A rat model of hepatic encephalopathy due to fulminant hepatic failure: the role of supportive therapy. In Advances in Ammonia Metabolism and Hepatic Encephalopathy. PB Soeters, IHP Wilson, AJ Meijer, E Holm (eds). Amsterdam, Elsevier Science Publishers, 1988, pp 213-217
30. International Federation of Clinical Chemistry: Committee on standards, Enzyme Panel. Clin Chem 24:720-721, 1978
31. Moss DW, Henderson AR, Kachmar JF: Enzymes. In Textbook of Clinical Chemistry. NW Tietz (ed). Philadelphia, WB Saunders Company, 1995, pp 706-713
32. Rock RC, Walker WG, Jennings CD: Nitrogen metabolites and renal function. In Textbook of Clinical Chemistry. NW Tietz (ed). Philadelphia, WB Saunders Company, 1995, pp 1268-1271
33. Balistreri WF, Shaw LM: Liver Function. In Textbook of Clinical Chemistry, NW Tietz (ed). Philadelphia, PA, WB Saunders Company, 1995, pp 1411-1412
34. Munro HN, Fleck A: Recent developments in the measurement of nucleic acids in biological materials. Analyst 91:78-88, 1966
35. Richards GM: Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal Biochem 57:369-376, 1974
36. 2 receptor antagonist on hepatic regeneration in rats. J Lab Clin Med 112:232-239, 1988
37. Lowry OH, Roscbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
38. LaBrecque DR, Feigenbaum A, Bachur NR: Diurnal rhythm: effects on hepatic regeneration and hepatic regenerative stimulator substance. Science 199:1082-1084, 1978
39. LaBrecque DR, Ssteele G, Fogerty S, Wilson M, Barton J: Purification and physical-chemical characterization of hepatic stimulator substance. Hepatology 7:100-106, 1988
40. LaBrecque DR, Bachur NR: Hepatic stimulator substance: physicochemical characteristics and specificity. Am J Physiol 242:G281-G288, 1982
41. Higgins GM, Anderson RM: Experimental pathology of the liver. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12:186-201, 1931
42. Mullen KD: Evaluation of the suitability of galactosamine-induced fulminant hepatic failure as a model of hepatic encephalopathy in the rat and rabbit. In Advances in Ammonia Metabolism and Hepatic Encephalopathy, PB Soeters, JHP Wilson, AJ Meijer, E Holm (eds). Amsterdam, Elsevier Science Publishers, 1988, pp 205-211
43. Kyprianidis KG, Mykoniatis MG, Papadimitriou DG, Valsamidou A: Effect of subtotal pancreatectomy on the rate of liver regeneration. The role of hepatic stimulator substance. J Surg Res 62:267-272, 1996
44. Liakos AA, Mykoniatis MG, Kokala ME, Papadimitriou DG, Liatsos G: Levels of hepatic stimulator substance in liver regenerating process of partially hepatectomized rats pretreated with a single dose of carbon tetrachloride. Dig Dis Sci 44:1046-1053, 1999
45. Wei A, Mao-Hua M: A study of the protective mechanism of hepatic stimulator substance against experimental acute liver failure in mice. Acta Physiol Sin 44(1):54-61, 1992
46. Fleig WE, Hoss G: Partial purification of rat stimulator substance and characterization of its action on hepatoma cells and normal hepatocytes. Hepatology 9(2):240-248, 1989
47. Hwang TL, Yu HC, Chen PC, Chen MF: Liver regeneration following partial hepatectomy and stimulation by hepatic stimulatory substance in cirrhotic and non cirrhotic rats. Res Exp Med (Berl) 195(4):201-208, 1995
48. Zhang BH, Gong DZ, Mei MH: Protection of regenerating liver after partial hepatectomy from carbon tetrachloride hepatotoxicity in rats: role of hepatic stimulator substance. J Gastroenterol Hepatol 14(10):1010-1017, 1999
49. Liu XJ, An W, Lei TG, Rong Y, Du GG: Regulatory effect of hepatic stimulator substance on the proliferation of human hepatoma cells. Sheng Li Xue Bao 50:543-550, 1998
50. An W, Liu XJ, Lei TG, Dai J, Du GG: Growth inhibition of hepatic stimulator substance in hepatocytes through its regulation on EGF receptors. Cell Res 9:37-49, 1999
51. Jiang B, Kasai S, Sawa M, Hirai S, Yamamoto T, Ebata H, Mito M: Beneficial effect of hepatic stimulatory substances on the survival of intrasplenically transplanted hepatocytes. Cell Transpl 2:325-329, 1993
52. Zhiqiang Y, Weisong Y, Wenbin Z, Yong C, Fengyi Y: Human hepatic regenerative stimulator substance: partial purification and biological characterization of hepatic stimulator substance from human fetal liver cells. Hepatology 12:1144-1151, 1990
53. Yao ZQ, Yang WS, Chen BF, Shang P, Zhang WB, Chen Y: Purification and characterization of human hepatic stimulator substance. Chin J Med (Engl) 106:527-532, 1993
54. 4-intoxication dissociated hepatocytes. Sheng Li Xue Bao 45:387-394, 1993
55. Yao ZQ, Yang WS, Zhang WB, Chen Y, Zhou YX: Hepatic stimulator substance from human fetal liver for treatment of experimental hepatic failure. Chin Med J (Engl) 105:676-683, 1992
56. Zhiqiang Y, Weisong Y, Benfu C, Peng S, Wenbin Z, Yong C: Purification and characterization of human hepatic stimulator substance. Chin Med J 106(7):527-532, 1993
57. Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng QH, Cillo U, Porter K, Starzl TE: Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors. Hepatology 16:1267-1270, 1992
58. Francavilla A, Azzarone A, Carrieri G, Cillo U, VanThiel D, Subbottin V, Starzl T: Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate Acetaminophen-induced liver failure. Hepatology 17:429-433, 1993
59. Guillaume D, Clamon L, LaBrecque DR: Hepatic stimulator substance (HSS) stimulates phosphoinositol hydrolysis. Hepatology 24(suppl):362 A, 1996
60. Liu XJ, An W, Lei TG, Rong Y, Du GG: Regulatory effect of hepatic stimulator substance on the proliferation of human hepatoma cells. Sheng Li Xue Bao 50:543-550, 1998
61. Margeli A, Theocharis S, Skaltsas S, Skopelitou A, Kittas C, Mykoniatis M, Varonos D: Effect of cadmium pretreatment on liver regeneration after partial hepatectomy in rats. Arch Toxicol 68:85-90, 1994
62. Jiang B, Sawa M, Yamamoto T, Kasai S: Enhancement of proliferation of intrasplenically transplanted hepatocytes in cirrhotic rats by hepatic stimulatory substance. Transplantation 63:131-135, 1997
63. He F, Wu C, Tu Q, Xing G: Human hepatic stimulator substance: a product of gene expression of human fetal liver tissue. Hepatology 17:225-229, 1993